HPS/PayMedix today announced it has closed $33 million in equity and debt financing to accelerate the growth of its groundbreaking PayMedix healthcare financing and payments solution. HLM Investment Partners, a leading healthcare investment firm, led a $16 million growth equity investment, joined by Escalate Capital Partners and RVM Enterprises, and existing investor SV Health Investors.

PayMedix is transforming how people access, use, and pay for healthcare by simplifying and consolidating healthcare information and payments for consumers and providers. Through guaranteed payments to providers, the SuperEOB®, and complete interest-free financing for consumers, PayMedix is the only platform that unifies all stakeholders through a single system. PayMedix has processed over $7 billion in medical payments for hospital systems and physician practices. The acquisition of TempoPay in 2024 expanded the company's interest-free financing platform to include pharmacy, dental, and vision expenses.